Terms: = Lymphoma AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Prognosis
125 results:
1. 2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
[TBL] [Abstract] [Full Text] [Related]
2. meta-analysis of decitabine pretreatment-based allogeneic hematopoietic stem cell transplantation affecting transplantation-related complications and prognosis in patients with malignant hematological disease.
Li L; Zhao Z; Li X
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):69-75. PubMed ID: 38279480
[TBL] [Abstract] [Full Text] [Related]
3. Low serum apolipoprotein A1 level predicts poor prognosis of patients with diffuse large B-cell lymphoma in the real world: a retrospective study.
Huang X; Wang Y; Huang Z; Chen X; Lin Q; Huang H; Fan L
BMC Cancer; 2024 Jan; 24(1):62. PubMed ID: 38212711
[TBL] [Abstract] [Full Text] [Related]
4. The role of α7-nAChR-mediated PI3K/AKT pathway in lung cancer induced by nicotine.
He Z; Xu Y; Rao Z; Zhang Z; Zhou J; Zhou T; Wang H
Sci Total Environ; 2024 Feb; 912():169604. PubMed ID: 38157907
[TBL] [Abstract] [Full Text] [Related]
5. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis.
Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X
Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751
[TBL] [Abstract] [Full Text] [Related]
6. Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.
Mark C; Meshinchi S; Joyce B; Gibson B; Harrison C; Bergmann AK; Goemans BF; Pronk CJH; Lapillonne H; Leverger G; Antoniou E; Schneider M; Attarbaschi A; Dworzak M; Stary J; Tomizawa D; Ebert S; Lejman M; Kolb EA; Schmiegelow K; Hasle H; Abla O
Br J Haematol; 2024 Feb; 204(2):576-584. PubMed ID: 37743097
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of genomic alterations in primary central nervous system lymphoma.
He X; Fan X; Shan Y; Ji X; Su L; Wang Y
Medicine (Baltimore); 2023 Sep; 102(35):e34931. PubMed ID: 37657032
[TBL] [Abstract] [Full Text] [Related]
8. The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjögren's syndrome: a single-centre, retrospective cohort study.
Mayer M; Martinic M; Reihl-Crnogaj M; Anic B
Rheumatol Int; 2023 Nov; 43(11):2031-2036. PubMed ID: 37491526
[TBL] [Abstract] [Full Text] [Related]
9. A Coumarin-Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins.
Nirgude S; Shahana M V ; Ravindran F; Kumar S; Sharma S; Mahadeva R; Mhatre A; Karki SS; Choudhary B
Molecules; 2023 Jul; 28(13):. PubMed ID: 37446888
[TBL] [Abstract] [Full Text] [Related]
10. The Role of Positron Emission Tomography for the Management of Sinonasal Malignancies: A Systematic Review.
El-Adem D; Yang N; Gudis DA
Am J Rhinol Allergy; 2023 Sep; 37(5):593-610. PubMed ID: 37229633
[TBL] [Abstract] [Full Text] [Related]
11. Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell lymphoma.
Wang ML; Jurczak W; Zinzani PL; Eyre TA; Cheah CY; Ujjani CS; Koh Y; Izutsu K; Gerson JN; Flinn I; Tessoulin B; Alencar AJ; Ma S; Lewis D; Lech-Maranda E; Rhodes J; Patel K; Maddocks K; Lamanna N; Wang Y; Tam CS; Munir T; Nagai H; Hernandez-Ilizaliturri F; Kumar A; Fenske TS; Seymour JF; Zelenetz AD; Nair B; Tsai DE; Balbas M; Walgren RA; Abada P; Wang C; Zhao J; Mato AR; Shah NN
J Clin Oncol; 2023 Aug; 41(24):3988-3997. PubMed ID: 37192437
[TBL] [Abstract] [Full Text] [Related]
12. Primary breast B-cell non-Hodgkin’s lymphoma of the breast. Case Report and review of the literature.
Santiago-Sanabria L; Garza-Arrieta J; Porras-Ibarra GD; Malfavón-Farias M
Rev Colomb Obstet Ginecol; 2023 Mar; 74(1):53-67. PubMed ID: 37093942
[TBL] [Abstract] [Full Text] [Related]
13. Cancer-associated spinal cord infarction: A systematic review and analysis of survival predictors.
Puente-Hernandez M; Rivero-de-Aguilar A; Varela-Lema L
J Neurol Sci; 2023 Mar; 446():120580. PubMed ID: 36764185
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical Features of Diffuse Large B-Cell lymphoma Transformed from Follicular lymphoma].
Zhang XL; Yu WJ; Zhu YN; Yang CM; Xiao F; Mai WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1772-1778. PubMed ID: 36476902
[TBL] [Abstract] [Full Text] [Related]
15. An integrative non-invasive malignant brain tumors classification and Ki-67 labeling index prediction pipeline with radiomics approach.
Zhang L; Liu X; Xu X; Liu W; Jia Y; Chen W; Fu X; Li Q; Sun X; Zhang Y; Shu S; Zhang X; Xiang R; Chen H; Sun P; Geng D; Yu Z; Liu J; Wang J
Eur J Radiol; 2023 Jan; 158():110639. PubMed ID: 36463703
[TBL] [Abstract] [Full Text] [Related]
16. An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma.
Izutsu K; Makita S; Nosaka K; Yoshimitsu M; Utsunomiya A; Kusumoto S; Morishima S; Tsukasaki K; Kawamata T; Ono T; Rai S; Katsuya H; Ishikawa J; Yamada H; Kato K; Tachibana M; Kakurai Y; Adachi N; Tobinai K; Yonekura K; Ishitsuka K
Blood; 2023 Mar; 141(10):1159-1168. PubMed ID: 36150143
[TBL] [Abstract] [Full Text] [Related]
17. JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
Gillessen S; Pluetschow A; Vucinic V; Ostermann H; Kobe C; Bröckelmann PJ; Böll B; Eichenauer DA; Heger JM; Borchmann S; Fuchs M; Borchmann P; Engert A; von Tresckow B
Eur J Haematol; 2022 Dec; 109(6):728-735. PubMed ID: 36056778
[TBL] [Abstract] [Full Text] [Related]
18. Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis.
Nie N; Zhou H; Zhang K; Liu L; Luo N; Wang R; Li X; Zhu M; Hu C; Wang Y; Liu Z; Li L; He Y
Thorac Cancer; 2022 Sep; 13(18):2574-2583. PubMed ID: 35896160
[TBL] [Abstract] [Full Text] [Related]
19. Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.
Fornecker LM; Lazarovici J; Aurer I; Casasnovas RO; Gac AC; Bonnet C; Bouabdallah K; Feugier P; Specht L; Molina L; Touati M; Borel C; Stamatoullas A; Nicolas-Virelizier E; Pascal L; Lugtenburg P; Di Renzo N; Vander Borght T; Traverse-Glehen A; Dartigues P; Hutchings M; Versari A; Meignan M; Federico M; André M;
J Clin Oncol; 2023 Jan; 41(2):327-335. PubMed ID: 35867960
[TBL] [Abstract] [Full Text] [Related]
20. Advances and Challenges in the Investigation of metastasis in Diffuse Large B-Cell lymphoma.
Chen Y; Jiang L; Liu L; Ruan M; Zhou Z; Yang M; Xia L
Mini Rev Med Chem; 2022; 22(22):2808-2812. PubMed ID: 35593342
[TBL] [Abstract] [Full Text] [Related]
[Next]
